Collegium Pharmaceutical Inc (COLL) financials · $1.12B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Collegium Pharmaceutical Inc (COLL) $1.12B cap.
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Revenue | $199.9M | $193.5M |
| Cost of Revenue | $89.6M | $76.3M |
| Gross Profit | $110.3M | $117.2M |
| Operating Income | $3.70M | $30.9M |
| Net Income | -$15.1M | $14.5M |
| EPS (Diluted) | -$0.46 | $0.40 |
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Assets | $2.14B | $1.65B |
| Current Assets | $608.0M | $745.7M |
| Cash & Equivalents | $129.5M | $268.6M |
| Inventory | $113.3M | $42.7M |
| PP&E | $10.7M | $11.7M |
| Total Liabilities | $1.82B | $1.34B |
| Current Liabilities | $589.9M | $435.0M |
| Shareholders' Equity | $311.9M | $312.4M |
| Retained Earnings | -$101.7M | -$86.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $329.3M | $205.0M |
| CapEx | $1.74M | $1.65M |
| Investing Cash Flow | -$63.5M | -$287.8M |
| Financing Cash Flow | -$110.2M | -$60.6M |
| Free Cash Flow | $327.6M | $203.3M |
FAQ
What is COLL P/E and revenue?
Collegium Pharmaceutical Inc (COLL) $1.12B cap.
What is COLL revenue?
Collegium Pharmaceutical Inc last cached revenue is $199.9M (Q2 2026).
Is COLL profitable?
Collegium Pharmaceutical Inc last cached net income is -$15.1M (Q2 2026).
What are COLL total assets?
Collegium Pharmaceutical Inc last cached total assets are $2.14B (Q2 2026).
What is COLL free cash flow?
Collegium Pharmaceutical Inc last cached free cash flow is $327.6M (FY2025).
Not investment advice. Cached statements, not a live tape.